GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 42 filers reported holding GENOCEA BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,016,000 | +7.8% | 4,012,404 | 0.0% | 0.20% | +18.9% |
| Q4 2021 | $4,654,000 | -39.6% | 4,012,404 | 0.0% | 0.17% | -43.9% |
| Q3 2021 | $7,704,000 | -17.9% | 4,012,404 | 0.0% | 0.30% | -14.5% |
| Q2 2021 | $9,389,000 | -13.7% | 4,012,404 | 0.0% | 0.35% | -13.7% |
| Q1 2021 | $10,874,000 | +12.0% | 4,012,404 | 0.0% | 0.41% | +6.8% |
| Q4 2020 | $9,710,000 | +5.7% | 4,012,404 | 0.0% | 0.38% | -23.6% |
| Q3 2020 | $9,188,000 | +97.9% | 4,012,404 | +98.8% | 0.50% | +74.8% |
| Q2 2020 | $4,642,000 | +28.5% | 2,018,398 | -3.9% | 0.29% | -15.1% |
| Q1 2020 | $3,613,000 | -16.9% | 2,100,305 | 0.0% | 0.34% | +2.1% |
| Q4 2019 | $4,348,000 | -28.6% | 2,100,305 | 0.0% | 0.33% | -48.4% |
| Q3 2019 | $6,091,000 | -26.0% | 2,100,305 | 0.0% | 0.64% | -28.8% |
| Q2 2019 | $8,233,000 | – | 2,100,305 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |